US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

337.90

+29.579.59%

Volume:386.04K

Turnover:128.75M

Market Cap:717.86M

PE:- -

High:340.20

Open:318.40

Low:318.40

Close:308.33

52wk High:341.93

52wk Low:66.95

Shares:2.12M

Float Shares:2.12M

Volume Ratio:1.14

T/O Rate:18.17%

Dividend:1.02

Dividend Rate:0.30%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Ship Healthcare Holdings Sees 1H Net Y5.50b

3 Australian Mining Stocks With Strong Profits and Balance Sheet Questions

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN) and ACADIA Pharmaceuticals (ACAD)

OLBA Healthcare Profit Slips as Balance Sheet Strengthens Ahead of DVx Integration

Citi Restructures North American Healthcare Investment Banking Team to Boost Competitive Edge in Medical Sector

Olba Healthcare Holdings FY Net Y1.11b vs Net Y1.43b

Analysts Conflicted on These Healthcare Names: C4 Therapeutics (CCCC), Codexis (CDXS) and LENZ Therapeutics (LENZ)

DRI Healthcare (DHT.UN) Receives a Buy from RBC Capital

Defensive Value Stocks Retail Investors Are Eyeing As Rates Stay Higher

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: Neurogene (NGNE) and Cardiff Oncology (CRDF)

Intelligent Bio Solutions Advances FDA Fingerprinting Drug Study

Analysts Offer Insights on Healthcare Companies: Mereo Biopharma Group Plc (MREO) and Inhibikase Therapeutics (IKT)

Belite Bio Wins FDA Priority Review for Tinlarebant in Stargardt Disease

What Is AbbVie (ABBV) Poised To Gain From FDA Review Of New BOTOX Use?

Simply Wall St.

Press Release: Spectral AI Announces 2026 Second Quarter Financial Results

Analyst Maintains Buy Rating on Achieve Life Sciences with Unchanged $17 Price Target, Backed by Cytisinicline Launch Readiness and FDA Pathway Clarity

Sector Update: Healthcare

MT Newswires Live

National Healthcare Declares Quarterly Dividend, Signals Ongoing Stability

Matt Phipps Initiates Buy on Upstream Bio, Citing Favorable FDA Progress and Best-in-Class Potential for Verekitug

Analysts Offer Insights on Healthcare Companies: Autolus Therapeutics (AUTL) and Cronos Group (CRON)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/LABU/news?page=20"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":337.9,"timestamp":1787680211820,"preClose":308.33,"halted":0,"volume":386040,"delay":0,"changeRate":0.09590373949988647,"floatShares":2124486,"shares":2124486,"eps":0,"marketStatus":"Trading","change":29.57,"latestTime":"08-25 13:50:19 EDT","open":318.4,"high":340.1999,"low":318.4,"amount":128748462.9072,"amplitude":0.070703,"askPrice":338.27,"askSize":50,"bidPrice":337.64,"bidSize":50,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":308.33,"sharesOutstanding":3074486,"nav":316.946,"aum":673347221.03,"dividendRate":0.003011,"bidAskSpread":0.002803,"preHourTrading":{"tag":"盘前","latestPrice":320.4,"preClose":308.33,"latestTime":"09:29 EDT","volume":4090,"amount":1297999.7005999999,"timestamp":1787664599999,"change":12.07,"changeRate":0.039146,"amplitude":0.037817},"postHourTrading":{"tag":"盘后","latestPrice":308.6,"preClose":308.33,"latestTime":"19:56 EDT","volume":2524,"amount":779026.005,"timestamp":1787615773057,"change":0.27,"changeRate":0.000876,"amplitude":0.011327},"volumeRatio":1.143896,"impliedVol":0.9899,"impliedVolPercentile":0.7928},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2124486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.143896,"shares":2124486,"dividePrice":1.0175,"high":340.1999,"amplitude":0.070703,"preClose":308.33,"low":318.4,"week52Low":66.95,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":337.9,"eps":0,"divideRate":0.003011,"volume":386040,"delay":0,"ttmEps":0,"open":318.4,"prevYearClose":159.39,"prevWeekClose":317.2,"prevMonthClose":227.4,"prevQuarterClose":292.1,"fiveDayClose":289.98,"twentyDayClose":242,"sixtyDayClose":195.3},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:20,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658969920","title":"Ship Healthcare Holdings Sees 1H Net Y5.50b","url":"https://stock-news.laohu8.com/highlight/detail?id=2658969920","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658969920?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:39","pubTimestamp":1786523940,"startTime":"0","endTime":"0","summary":"Ship Healthcare Holdings Inc. also released the following forecasts:. Results are based on Japanese accounting standards.This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4137","LU0029874061.USD","BK4581","LABU","LU0128526141.USD","BK4585","HCSG","XLV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658973492","title":"3 Australian Mining Stocks With Strong Profits and Balance Sheet Questions","url":"https://stock-news.laohu8.com/highlight/detail?id=2658973492","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658973492?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:33","pubTimestamp":1786523629,"startTime":"0","endTime":"0","summary":"Global bond yields rose recently as markets reacted to higher oil prices and inflation worries. That push and pull between energy costs and interest rate expectations keeps many large caps on a tight leash. It also helps Financially Fit Penny Stocks stand out: you get smaller companies where balance sheet strength matters most. This article highlights three stocks from the screener that could deserve a closer look now.\nThe three Financially Fit Penny Stocks highlighted below are only a...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-obm/ora-banda-mining-shares/news/3-australian-mining-stocks-with-strong-profits-and-balance-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-obm/ora-banda-mining-shares/news/3-australian-mining-stocks-with-strong-profits-and-balance-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SGDM","DZZ","LABU","GDXD","GBUG","GLTR","OUNZ","BAR","UGL","XLV","RING","BTGD","PPI","SHNY","GDXJ","DGP","PMDE","FGDL","IAUI","DUST","OBM.AU","XME","SGOL","BEGS","PHYS","GDXY","GOAU","GOLY","DECU","IAUM","JDST","UYM","GLDM","SIG.AU","XKO.AU","IAU","USG","PICK","CEF","GLL","XJO.AU","DULL","VOTE","XAO.AU","AAAU","DBC","ALK.AU","GDX","GDXU","JNUG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658927217","title":"Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN) and ACADIA Pharmaceuticals (ACAD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658927217","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658927217?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:10","pubTimestamp":1786522207,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Elanco Animal Health (ELAN) and ACADIA Pharmaceutica...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-elanco-animal-health-elan-and-acadia-pharmaceuticals-acad-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-elanco-animal-health-elan-and-acadia-pharmaceuticals-acad-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065171311.SGD","BK4139","BK4007","LU2065171402.SGD","HCSG","BK4137","BK4561","LU1941712348.USD","BK4581","ELAN","LU0128526141.USD","ACAD","LU2065169927.USD","XBI","LU0029874061.USD","LU1941712264.USD","XLV","LU2065170008.USD","BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658245269","title":"OLBA Healthcare Profit Slips as Balance Sheet Strengthens Ahead of DVx Integration","url":"https://stock-news.laohu8.com/highlight/detail?id=2658245269","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658245269?lang=en_us&edition=fundamental","pubTime":"2026-08-12 14:59","pubTimestamp":1786517941,"startTime":"0","endTime":"0","summary":"OLBA HEALTHCARE HOLDINGS, Inc. ( ($JP:2689) ) has issued an update. OLBA Healthcare Holdings reported consolidated net sales of ¥126,595 million fo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/olba-healthcare-profit-slips-as-balance-sheet-strengthens-ahead-of-dvx-integration?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/olba-healthcare-profit-slips-as-balance-sheet-strengthens-ahead-of-dvx-integration?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LU0029874061.USD","BK4588","XLV","HCSG","XBI","BK4137","LU0128526141.USD","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194590602","title":"Citi Restructures North American Healthcare Investment Banking Team to Boost Competitive Edge in Medical Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=1194590602","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194590602?lang=en_us&edition=fundamental","pubTime":"2026-08-12 14:34","pubTimestamp":1786516479,"startTime":"0","endTime":"0","summary":"Citi Group (C.US) has recently appointed several new leaders for its healthcare investment banking division, aiming to elevate its industry standing and sharpen its competitive edge in the booming...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0477156953.USD","LU2456880835.USD","LU0162691827.USD","LU0170899867.USD","BK4504","BK4207","LU0314106906.USD","LU0648001328.SGD","VHT","LU1244550577.SGD","LU1267930227.SGD","LU0310800965.SGD","159760","159891","BK4534","LU1506573853.SGD","XBI","BK4550","LU1074936037.SGD","LU1201861249.SGD","IE00BSNM7G36.USD","IYF","LU0203345920.USD","LU0203347892.USD","BK4588","LU1162221912.USD","LU1668664300.SGD","C","LU1244550221.USD","LU2360032135.SGD","LABU","LU0098860793.USD","LU2125154935.USD","LU0130517989.USD","FTXO","BK4581","LU0106831901.USD","LU0980610538.SGD","BK4585","TFNS","LU2462157665.USD","XLV","LU0128525689.USD","LU0320765646.SGD","LU1366192091.USD","LU1244550494.USD","LU0130102774.USD","LU1791807156.HKD","LU2125154778.USD","LU2417539215.USD","BK4566","BK4559","LU2236285917.USD","LU0052756011.USD","IXJ","LU0072461881.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658921579","title":"Olba Healthcare Holdings FY Net Y1.11b vs Net Y1.43b","url":"https://stock-news.laohu8.com/highlight/detail?id=2658921579","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658921579?lang=en_us&edition=fundamental","pubTime":"2026-08-12 14:30","pubTimestamp":1786516200,"startTime":"0","endTime":"0","summary":"Results are based on Japanese accounting standards.This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","LU0029874061.USD","HCSG","LU0128526141.USD","BK4581","BK4585","BK4137","XBI","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658792541","title":"Analysts Conflicted on These Healthcare Names: C4 Therapeutics (CCCC), Codexis (CDXS) and LENZ Therapeutics (LENZ)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658792541","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658792541?lang=en_us&edition=fundamental","pubTime":"2026-08-12 13:20","pubTimestamp":1786512014,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on C4 Therapeutics (CCCC), Codexis (CDXS) and LENZ Therapeutics (LEN...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-c4-therapeutics-cccc-codexis-cdxs-and-lenz-therapeutics-lenz-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-c4-therapeutics-cccc-codexis-cdxs-and-lenz-therapeutics-lenz-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","CDXS","LABU","BK4581","HCSG","XBI","LU0128526141.USD","BK4585","LU0029874061.USD","BK4121","CCCC","XLV","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658756947","title":"DRI Healthcare (DHT.UN) Receives a Buy from RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2658756947","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658756947?lang=en_us&edition=fundamental","pubTime":"2026-08-12 09:45","pubTimestamp":1786499153,"startTime":"0","endTime":"0","summary":"In a report released on August 10, Douglas Miehm from RBC Capital maintained a Buy rating on DRI Healthcare, with a price target of C$21.00. The co...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/dri-healthcare-dht-un-receives-a-buy-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/dri-healthcare-dht-un-receives-a-buy-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1267930573.SGD","LU0154245673.USD","BK4209","GSIB","BK4207","BK4504","HCSG","LU0029864427.USD","BK4137","LU0708994859.HKD","BK4581","LU0128526141.USD","LU0310800379.SGD","XBI","LU0029874061.USD","DRI","XLV","LU0128525929.USD","BK4585","LU0154245756.USD","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658947322","title":"Defensive Value Stocks Retail Investors Are Eyeing As Rates Stay Higher","url":"https://stock-news.laohu8.com/highlight/detail?id=2658947322","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658947322?lang=en_us&edition=fundamental","pubTime":"2026-08-12 07:36","pubTimestamp":1786491397,"startTime":"0","endTime":"0","summary":"With the Federal Reserve hinting that interest rates may stay higher for longer and inflation still running above target, many investors are rethinking where to park their cash. This backdrop puts fresh attention on value stocks from defensive sectors, where steadier cash flows and dividends can matter more. This article walks through three stocks from our Value Stocks screener that appear well placed in light of the latest Fed signals.\nThe three stocks highlighted below are just a starting...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-reg/regis-healthcare-shares/news/defensive-value-stocks-retail-investors-are-eyeing-as-rates","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-reg/regis-healthcare-shares/news/defensive-value-stocks-retail-investors-are-eyeing-as-rates","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XLV","PMDE","REG.AU","EIGA.AU","BK4211","VAP.AU","BK7124","GIVE.AU","BK4585","ZYAU.AU","OZF.AU","QFN.AU","IIGF.AU","DECU","ISBC","SLF.AU","JOYT","OZR.AU","GEAR.AU","XJO.AU","GXDW","XBI","IOZ.AU","XAO.AU","DACE.AU","BK7113","BK4581","E200.AU","BK4588","XKO.AU","ACL.AU","VAS.AU","LABU","QRE.AU","RGLO","IISV.AU","VOTE","BBOZ.AU","STW.AU","BEAR.AU","IMLC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658416509","title":"Analysts Offer Insights on Healthcare Companies: Neurogene (NGNE) and Cardiff Oncology (CRDF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658416509","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658416509?lang=en_us&edition=fundamental","pubTime":"2026-08-12 07:20","pubTimestamp":1786490407,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Neurogene (NGNE) and Cardiff Oncology (CRDF). Neur...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neurogene-ngne-and-cardiff-oncology-crdf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neurogene-ngne-and-cardiff-oncology-crdf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","XLV","BK4581","LU0128526141.USD","NGNE","BK4585","LABU","HCSG","BK4588","BK4137","CRDF","XBI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658493229","title":"Intelligent Bio Solutions Advances FDA Fingerprinting Drug Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2658493229","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658493229?lang=en_us&edition=fundamental","pubTime":"2026-08-12 05:54","pubTimestamp":1786485274,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Intelligent Bio Solutions ( ($INBS) ). On August 11, 2026, Intelligent Bio Solutions announced it had completed...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/intelligent-bio-solutions-advances-fda-fingerprinting-drug-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/intelligent-bio-solutions-advances-fda-fingerprinting-drug-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658949348","title":"Analysts Offer Insights on Healthcare Companies: Mereo Biopharma Group Plc (MREO) and Inhibikase Therapeutics (IKT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658949348","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658949348?lang=en_us&edition=fundamental","pubTime":"2026-08-12 05:50","pubTimestamp":1786485007,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Mereo Biopharma Group Plc (MREO) and Inhibikase Th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mereo-biopharma-group-plc-mreo-and-inhibikase-therapeutics-ikt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mereo-biopharma-group-plc-mreo-and-inhibikase-therapeutics-ikt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","XLV","BK4581","LU0029874061.USD","BK4585","BK4588","XBI","MREO","BK4505","BK4139","BK4137","HCSG","LU0128526141.USD","IKT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658994577","title":"Belite Bio Wins FDA Priority Review for Tinlarebant in Stargardt Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2658994577","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658994577?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:49","pubTimestamp":1786481371,"startTime":"0","endTime":"0","summary":"Belite Bio, Inc. ADR ( ($BLTE) ) has provided an announcement. On August 11, 2026, Belite Bio announced that the U.S. Food and Drug Administration ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/belite-bio-wins-fda-priority-review-for-tinlarebant-in-stargardt-disease?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/belite-bio-wins-fda-priority-review-for-tinlarebant-in-stargardt-disease?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APIE","DINT","CVY","SAPH","AADR","LABU","BK4585","ARMH","DIVL","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658946437","title":"What Is AbbVie (ABBV) Poised To Gain From FDA Review Of New BOTOX Use?","url":"https://stock-news.laohu8.com/highlight/detail?id=2658946437","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658946437?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:45","pubTimestamp":1786481115,"startTime":"0","endTime":"0","summary":"AbbVie (NYSE:ABBV) said the FDA has accepted for review a supplemental Biologics License Application for BOTOX Cosmetic to treat masseter muscle prominence in the U.S.\nThe filing positions BOTOX Cosmetic as a potential first approved neurotoxin for this jawline contouring indication, expanding AbbVie’s facial aesthetics reach beyond wrinkle treatment.\nAbbVie is seeking to build on Phase 3 data that supported efficacy and safety in adults seeking non surgical jawline contouring...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/141885706-main-header/1756256222285","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/141885706-main-header/1756256222285"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-abbv/abbvie/news/what-is-abbvie-abbv-poised-to-gain-from-fda-review-of-new-bo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-abbv/abbvie/news/what-is-abbvie-abbv-poised-to-gain-from-fda-review-of-new-bo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2089284900.SGD","LU2237443465.HKD","SG9999001440.SGD","PPH","GLAM","LU1670627923.USD","LU0310800379.SGD","IXJ","LU1061106388.HKD","LU0198837287.USD","JDOC","LU0128525929.USD","LU0234570918.USD","LU1496350171.SGD","LU2089283258.USD","LU0289739699.SGD","LU1074936037.SGD","XLV","LU2125909593.SGD","ABBV","IE00BFTCPJ56.SGD","LU0203345920.USD","RXL","LU0965508806.USD","IE0009355771.USD","LU2237443622.USD","IE0000B7K699.USD","IE000BZT7R73.USD","FTXH","BK4534","LU0882574055.USD","LU0868494708.USD","IYH","LABU","LU0289961442.SGD","LU1732799900.SGD","TRUH","LU2237443895.HKD","MEDX","VHT","IE0002270589.USD","IE00BJJMRZ35.SGD","IE00BVYPNW00.USD","PJP","IE000SO60NU8.SGD","LU2347655156.SGD","AGNG","LU2089984988.USD","FHLC","SG9999015952.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658948230","title":"Press Release: Spectral AI Announces 2026 Second Quarter Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658948230","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658948230?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:05","pubTimestamp":1786478700,"startTime":"0","endTime":"0","summary":"Indication; with this classification, Spectral AI is now authorized to. commence commercial distribution activities in the United States.-- In March 2026, awarded $31.7 million of advanced funding from the. accelerate and support additional development and procurement for the. -- Following the receipt of FDA clearance for the DeepView System, drew $6.5. million under our existing credit facility with Avenue Capital Group,providing non-dilutive capital to further strengthen the Company's. -- Expanded leadership team in advance of commercial activities, including. the appointments of David McGuire as Chief Financial Officer and Darcy. -- Completed all remaining milestones under our Department of Defense. contract for the DeepView System handheld device, contracted through the. Medical Technology Enterprise Consortium , including the delivery. -- Commenced label expansion of the DeepView System to include heads, hands","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","VTHR","BK4082","QTOC","CHAT","BK4022","AGIX","AIPO","BK4585","LABU","MDAI","R","BK4588","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658991075","title":"Analyst Maintains Buy Rating on Achieve Life Sciences with Unchanged $17 Price Target, Backed by Cytisinicline Launch Readiness and FDA Pathway Clarity","url":"https://stock-news.laohu8.com/highlight/detail?id=2658991075","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658991075?lang=en_us&edition=fundamental","pubTime":"2026-08-12 03:35","pubTimestamp":1786476926,"startTime":"0","endTime":"0","summary":"In a report released today, Patrick Dolezal from LifeSci Capital maintained a Buy rating on Achieve Life Sciences, with a price target of $17.00. P...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-maintains-buy-rating-on-achieve-life-sciences-with-unchanged-17-price-target-backed-by-cytisinicline-launch-readiness-and-fda-pathway-clarity-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-maintains-buy-rating-on-achieve-life-sciences-with-unchanged-17-price-target-backed-by-cytisinicline-launch-readiness-and-fda-pathway-clarity-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658891047","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2658891047","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658891047?lang=en_us&edition=fundamental","pubTime":"2026-08-12 03:28","pubTimestamp":1786476514,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined late Tuesday afternoon, with the NYSE Healthcare Index shedding 0.4% and the State Street Health Care Select Sector SPDR ETF  down 0.2%.The iShares Biotechnology ETF  decreased 0.2%.In corporate news, Tactile Systems Technology  shares fell nearly 18% after it reported late Monday its Q2 results and lowered its revenue guidance for the full year.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XBI","BK4581","BK4137","BK4082","HCSG","BK4585","BK4588","LU0128526141.USD","TCMD","LU0029874061.USD","LABU","XLV","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658910278","title":"National Healthcare Declares Quarterly Dividend, Signals Ongoing Stability","url":"https://stock-news.laohu8.com/highlight/detail?id=2658910278","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658910278?lang=en_us&edition=fundamental","pubTime":"2026-08-12 03:18","pubTimestamp":1786475918,"startTime":"0","endTime":"0","summary":"National Healthcare ( ($NHC) ) has issued an update. On August 6, 2026, National HealthCare Corporation announced it will pay a quarterly cash divi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/national-healthcare-declares-quarterly-dividend-signals-ongoing-stability?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/national-healthcare-declares-quarterly-dividend-signals-ongoing-stability?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","XLV","BK4581","BK4585","BK4588","XBI","BK4185","NHC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658221910","title":"Matt Phipps Initiates Buy on Upstream Bio, Citing Favorable FDA Progress and Best-in-Class Potential for Verekitug","url":"https://stock-news.laohu8.com/highlight/detail?id=2658221910","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658221910?lang=en_us&edition=fundamental","pubTime":"2026-08-12 03:05","pubTimestamp":1786475121,"startTime":"0","endTime":"0","summary":"William Blair analyst Matt Phipps has maintained their bullish stance on UPB stock, giving a Buy rating today. Matt Phipps has given his Buy rating...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/matt-phipps-initiates-buy-on-upstream-bio-citing-favorable-fda-progress-and-best-in-class-potential-for-verekitug-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/matt-phipps-initiates-buy-on-upstream-bio-citing-favorable-fda-progress-and-best-in-class-potential-for-verekitug-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4097","BK4588","BK4139","LU2065732104.USD","UPB","PRGS","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658910604","title":"Analysts Offer Insights on Healthcare Companies: Autolus Therapeutics (AUTL) and Cronos Group (CRON)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658910604","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658910604?lang=en_us&edition=fundamental","pubTime":"2026-08-12 03:00","pubTimestamp":1786474815,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Autolus Therapeutics (AUTL) and Cronos Group (CRON) ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-autolus-therapeutics-autl-and-cronos-group-cron-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-autolus-therapeutics-autl-and-cronos-group-cron-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MJ","BK4588","BK4137","LU0128526141.USD","HCSG","YOLO","XLV","CRON","LABU","LU0029874061.USD","BK4581","BK4007","AUTL","BK4585","BK4557","XBI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":20,"totalSize":407,"code":"91000000","status":"200"}]}}